Free Trial
→ $30 stock to buy before Starlink goes public (WATCH NOW!) (From Paradigm Press) (Ad)tc pixel Free SPEC Stock Alerts

Spectaire (SPEC) Competitors

Spectaire logo
$0.0005 0.00 (0.00%)
As of 05/1/2026
Compare

SPEC vs. THMO, HTGMQ, OLITW, PRENW, and QSIAW

Should you be buying Spectaire stock or one of its competitors? The main competitors of Spectaire include ThermoGenesis (THMO), HTG Molecular Diagnostics (HTGMQ), OmniLit Acquisition (OLITW), Prenetics Global (PRENW), and Quantum-Si (QSIAW). These companies are all part of the "measuring and control equipment" industry.

How does Spectaire compare to ThermoGenesis?

Spectaire (NASDAQ:SPEC) and ThermoGenesis (NASDAQ:THMO) are both small-cap measuring and control equipment companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, dividends, risk, profitability, analyst recommendations, media sentiment and institutional ownership.

26.5% of Spectaire shares are held by institutional investors. Comparatively, 5.8% of ThermoGenesis shares are held by institutional investors. 25.4% of Spectaire shares are held by insiders. Comparatively, 78.0% of ThermoGenesis shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, Spectaire's average media sentiment score of 0.00 equaled ThermoGenesis'average media sentiment score.

Company Overall Sentiment
Spectaire Neutral
ThermoGenesis Neutral

Spectaire has higher earnings, but lower revenue than ThermoGenesis. Spectaire is trading at a lower price-to-earnings ratio than ThermoGenesis, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SpectaireN/AN/A$8.95M-$0.30N/A
ThermoGenesis$9.61M0.00-$17.98M-$5.14N/A

Spectaire has a beta of -6.91, meaning that its stock price is 791% less volatile than the S&P 500. Comparatively, ThermoGenesis has a beta of 1.1, meaning that its stock price is 10% more volatile than the S&P 500.

ThermoGenesis' return on equity of 0.00% beat Spectaire's return on equity.

Company Net Margins Return on Equity Return on Assets
SpectaireN/A -81.22% 304.57%
ThermoGenesis N/A N/A N/A

Summary

ThermoGenesis beats Spectaire on 5 of the 9 factors compared between the two stocks.

How does Spectaire compare to HTG Molecular Diagnostics?

Spectaire (NASDAQ:SPEC) and HTG Molecular Diagnostics (NASDAQ:HTGMQ) are both measuring and control equipment companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, earnings, profitability, dividends, analyst recommendations, valuation, media sentiment and institutional ownership.

Spectaire has higher earnings, but lower revenue than HTG Molecular Diagnostics. Spectaire is trading at a lower price-to-earnings ratio than HTG Molecular Diagnostics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SpectaireN/AN/A$8.95M-$0.30N/A
HTG Molecular Diagnostics$6.37M0.00-$21.59M-$2.28N/A

HTG Molecular Diagnostics' return on equity of 0.00% beat Spectaire's return on equity.

Company Net Margins Return on Equity Return on Assets
SpectaireN/A -81.22% 304.57%
HTG Molecular Diagnostics N/A N/A N/A

26.5% of Spectaire shares are held by institutional investors. 25.4% of Spectaire shares are held by insiders. Comparatively, 2.6% of HTG Molecular Diagnostics shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, Spectaire's average media sentiment score of 0.00 equaled HTG Molecular Diagnostics'average media sentiment score.

Company Overall Sentiment
Spectaire Neutral
HTG Molecular Diagnostics Neutral

Spectaire has a beta of -6.91, indicating that its stock price is 791% less volatile than the S&P 500. Comparatively, HTG Molecular Diagnostics has a beta of 3.25, indicating that its stock price is 225% more volatile than the S&P 500.

Summary

Spectaire beats HTG Molecular Diagnostics on 5 of the 9 factors compared between the two stocks.

How does Spectaire compare to OmniLit Acquisition?

Spectaire (NASDAQ:SPEC) and OmniLit Acquisition (NASDAQ:OLITW) are both measuring and control equipment companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, profitability, media sentiment, risk, institutional ownership, earnings, dividends and analyst recommendations.

In the previous week, Spectaire's average media sentiment score of 0.00 equaled OmniLit Acquisition'saverage media sentiment score.

Company Overall Sentiment
Spectaire Neutral
OmniLit Acquisition Neutral

26.5% of Spectaire shares are owned by institutional investors. 25.4% of Spectaire shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SpectaireN/AN/A$8.95M-$0.30N/A
OmniLit AcquisitionN/AN/AN/AN/AN/A

OmniLit Acquisition's return on equity of 0.00% beat Spectaire's return on equity.

Company Net Margins Return on Equity Return on Assets
SpectaireN/A -81.22% 304.57%
OmniLit Acquisition N/A N/A N/A

Summary

Spectaire beats OmniLit Acquisition on 3 of the 4 factors compared between the two stocks.

How does Spectaire compare to Prenetics Global?

Prenetics Global (NASDAQ:PRENW) and Spectaire (NASDAQ:SPEC) are both measuring and control equipment companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, dividends, risk, media sentiment, institutional ownership, earnings, profitability and analyst recommendations.

26.5% of Spectaire shares are held by institutional investors. 25.4% of Spectaire shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, Prenetics Global's average media sentiment score of 0.00 equaled Spectaire'saverage media sentiment score.

Company Overall Sentiment
Prenetics Global Neutral
Spectaire Neutral

Prenetics Global's return on equity of 0.00% beat Spectaire's return on equity.

Company Net Margins Return on Equity Return on Assets
Prenetics GlobalN/A N/A N/A
Spectaire N/A -81.22%304.57%

Spectaire has lower revenue, but higher earnings than Prenetics Global.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Prenetics Global$92.39MN/AN/AN/AN/A
SpectaireN/AN/A$8.95M-$0.30N/A

Summary

Spectaire beats Prenetics Global on 3 of the 5 factors compared between the two stocks.

How does Spectaire compare to Quantum-Si?

Spectaire (NASDAQ:SPEC) and Quantum-Si (NASDAQ:QSIAW) are both measuring and control equipment companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, profitability, earnings, analyst recommendations, risk, institutional ownership and media sentiment.

26.5% of Spectaire shares are held by institutional investors. 25.4% of Spectaire shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, Spectaire's average media sentiment score of 0.00 equaled Quantum-Si'saverage media sentiment score.

Company Overall Sentiment
Spectaire Neutral
Quantum-Si Neutral

Quantum-Si's return on equity of 0.00% beat Spectaire's return on equity.

Company Net Margins Return on Equity Return on Assets
SpectaireN/A -81.22% 304.57%
Quantum-Si N/A N/A N/A

Spectaire has higher earnings, but lower revenue than Quantum-Si.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SpectaireN/AN/A$8.95M-$0.30N/A
Quantum-Si$2.44MN/AN/AN/AN/A

Summary

Spectaire beats Quantum-Si on 3 of the 5 factors compared between the two stocks.

Get Spectaire News Delivered to You Automatically

Sign up to receive the latest news and ratings for SPEC and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SPEC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SPEC vs. The Competition

Export
MetricSpectaireMeasuring & controlling devices IndustryComputer SectorNASDAQ Exchange
Market Cap$9K$94.69M$37.15B$11.87B
Dividend YieldN/A10.64%3.16%5.21%
P/E Ratio0.006.0377.8328.47
Price / SalesN/A8.24617.9660.94
Price / CashN/A8.3846.3136.52
Price / Book0.001.299.176.67
Net Income$8.95M$7.16M$1.03B$332.53M
7 Day PerformanceN/A-2.76%4.88%2.01%
1 Month PerformanceN/A-2.31%14.33%9.20%
1 Year PerformanceN/A181.81%168.77%39.59%

Spectaire Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SPEC
Spectaire
N/A$0.00
flat		N/AN/A$9KN/AN/A8
THMO
ThermoGenesis
N/A$0.00
flat		N/AN/A$1K$9.61MN/A40
HTGMQ
HTG Molecular Diagnostics
N/AN/AN/AN/A$0.00$6.37MN/A90
OLITW
OmniLit Acquisition
N/A$1.40
-18.6%		N/AN/A$0.00N/AN/A3
PRENW
Prenetics Global
N/A$0.02
-1.1%		N/AN/A$0.00$92.39MN/A1

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:SPEC) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Sell 99% of Your Stocks, Do THIS Instead…
Millionaire Trader Exposes: "The Single Stock Income Plan" With over 6,000 stocks on the market to choose ...
The Oxford Club | Sponsoredtc pixel
Trade this between 9:30 and 10:45 am EST
The first 75 minutes of the trading day may be the most overlooked window for consistent opportunities.If you ...
Base Camp Trading | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Elon Unveils AI Passive Income Stream for Millions of Americans
During Tesla's last earnings call, Elon Musk outlined a new AI-driven approach he says could generate $30,000-...
InvestorPlace | Sponsoredtc pixel
Invest in SpaceX Before IPO
SpaceX is already one of the most valuable private companies on Earth, and some analysts believe its valuation...
NXT Wave Research | Sponsoredtc pixel
URGENT: $2 Gold Stock With Major Discovery
A $2 gold stock is said to quietly control what may be the largest gold deposit in the world - worth nearly $1...
Paradigm Press | Sponsoredtc pixel